AACE In the news

July 10, 2024 | NPR News

Ozempic's Popularity Leads to Shortages for People with Type 2 Diabetes

Due to the popularity of Ozempic, there is a shortage affecting people with Type 2 diabetes. Telehealth company Ro has created a free online tool to help patients report these shortages. By mid-June, within the first two weeks of its launch, their tracker received 35,000 reports of shortages. AACE President Elect, Scott D. Isaacs, MD, FACP, FACE, explains in an NPR News article the significant overlap between patients with Type 2 diabetes and those needing GLP-1s for weight loss, and how both groups of patients require their medications.

June 11, 2024 | AACE Media

AACE Annual Meeting 2024 Media Coverage

Our 2024 Annual Meeting in New Orleans attracted significant media attention, highlighting our dedication to advancing the field of endocrinology. Explore over 35 national press articles showcasing key insights, groundbreaking research, and innovative treatments presented during our event.

June 10, 2024 | Everyday Health

Diabetes and Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)

More than one in four people with type 2 diabetes have metabolic dysfunction–associated steatotic liver disease (MASLD), and more than three in four people with MASLD have diabetes. Despite having different symptoms, these conditions share several of the same underlying causes, and many people wind up living with both diseases without even knowing it. AACE President Elect, Scott D. Isaacs, MD, FACP, FACE, discusses medication options, lifestyle changes, and prevention strategies for type 2 diabetes and MASLD in an article by Everyday Health.

June 7, 2024 | NPR News

Thinking of Buying Wegovy Online. Here’s What to Know About Compounding Pharmacies

With the increasing demand for weight-loss drugs such as Wegovy, compounding pharmacies are providing cheaper alternatives. Although the cost can be appealing, there are some risks. AACE President Elect, Scott D. Isaacs, MD, FACP, FACE, emphasizes the importance for patients to maintain open communication with their doctors about any alternative medications to monitor for side effects and necessary dose adjustments, in an article by NPR News.

May 13, 2024 | Wall Street Journal

A Lot of What You’ve Heard About Cortisol Is Wrong

If you’ve noticed people talking about managing their cortisol lately, you’re not alone. Chatter about the stress hormone has surged. A rare condition called adrenal insufficiency can occur when people produce too little cortisol. AACE President Elect, Scott D. Isaacs, MD, FACP, FACE, shares the lowdown on ‘adrenal fatigue’ and how to manage cortisol levels in an article published by The Wall Street Journal.

May 10, 2024 | Healio

Screening for Liver Disease is An Integral Component of Metabolic Care

AACE Past President, Jonathan D. Leffert, MD, talks with Sangeeta Kashyap, MD, and AACE President Elect, Scott D. Isaacs, MD, FACP, FACE, about nomenclature for liver disease and how endocrinologists should approach screening and treatment.

March 26, 2024 | The Wall Street Journal

Do You Really Need to Know What Your Blood Sugar Is Doing All Day Long?

People without diabetes will soon be able to track their glucose levels more easily. It isn’t clear whether they should. How closely should you be tracking your blood-sugar levels? AACE President Elect, Scott D. Isaacs, MD, FACP, FACE, provides insights in an article published by The Wall Street Journal.

February 28, 2024 | Fox News

Ask a doc: ‘Why am I always thirsty — and what should I do about it?'

If you're always thirsty even though you try your best to drink water and stay hydrated, there may be health-related reasons. AACE Member, Atil Kargi, MD, a clinical endocrinologist in the department of neurosurgery at the University of North Carolina at Chapel Hill, explains the causes in an article published by Fox News Digital.

January 23, 2024 | Healthline

Would You Change Jobs to Get Ozempic, Wegovy Coverage? 20% of Americans Say, 'Yes'

The desire for access to anti-obesity medication is so strong that people are more interested in coverage for these medications than other work perks, including child care. AACE Immediate Past President Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, anticipates that employers may be incentivized to update their health insurance policies depending on how tight the job market is, in an article featured on healthline.com.

December 6, 2023 | Health

People Taking Ozempic, Wegovy May See Additional Sleep Apnea Benefits

GLP-1 drugs, like Ozempic and Wegovy, may help people sleep better. AACE President Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, and AACE member Karl Nadolsky, DO, FACE, DABOM, explain how GLP-1 medications can help with sleep issues, particularly sleep apnea, in an article featured on health.com.

November 15, 2023 | Healthline

Black People Are Facing Greater Challenges Accessing Anti-Obesity Drugs Like Ozempic and Wegovy

As the popularity of Ozempic and Wegovy soar for their weight loss benefits, some doctors are concerned about disparities regarding access to these drugs. Fewer Black and Hispanic people are prescribed these medications, yet they are at greater risk for developing type 2 diabetes. AACE President Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, explains ways to make anti-obesity medications more accessible for everyone, in an article featured on healthline.com.

November 3, 2023 | Healthline

Usher Opens Up About His Child's Type 1 Diabetes Journey and How Earlier Detection Can Help

Grammy award-winning singer, songwriter, and dancer, Usher, is speaking out about his child’s journey with type 1 diabetes (T1D), and how early screening can help prepare parents and their children before T1D advances. Rifka C. Schulman-Rosenbaum, MD, chair of the AACE Diabetes Disease State Network, explains the three stages of T1D and the importance for early screening, in an article featured on healthline.com.

November 1, 2023 | Healthline

Ozempic and Other GLP-1 Drugs May Contribute to Higher Levels of Social Anxiety

Ozempic and other anti-obesity medications can improve health and aid with significant weight loss. However, with significant weight loss may come anxiety about people’s reactions and views of you. AACE President Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, shares ways to cope with the newfound attention, in an article featured on healthline.com.

October 24, 2023 | Healthline

What to Know Before Taking Obesity Drugs While on Birth Control

GLP-1 receptor drugs, like Mounjaro, may hinder the effectiveness of oral contraceptives. It’s recommended that people taking Mounjaro switch to a non-oral birth control method or add a barrier method of contraception in the timeframe around a dose of the GLP-1 drug. Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, and Karl Nadolsky, DO, FACE, DABOM, explain how some forms of contraception may interact with GLP-1 drugs, in an article featured on health.com.

October 2, 2023 | Healthline

Ozempic Doesn’t Warn About Mental Health Side Effects, but Wegovy Does

Ozempic does not list anxiety, depression, or suicidal thoughts on its label, yet Wegovy’s label does. The active ingredient in both Ozempic and Wegovy is semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist. AACE President Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, explains how semaglutide can affect your mental health, in an article featured on healthline.com.

October 2, 2023 | Healthline

Managing Type 1 Diabetes Isn’t Rocket Science for This NASA Aerospace Engineer

People with type 1 diabetes are disqualified from flying to space. Rifka Chaya Schulman-Rosenbaum, MD, and Karl Nadolsky, DO, FACE, DABOM, explain how a diagnosis of type 1 diabetes in most cases would not limit career choices, in an article featured on healthline.com.

September 27, 2023 | CNN

CNN Exclusive: Prescriptions for Popular Diabetes and Weight-loss Drugs Soared, but Access is Limited for Some Patients

AACE President Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, shares insights about AACE's development of an obesity algorithm to help stratify the risk of obesity and guide treatment decisions based on a holistic assessment of an individual’s clinical risk factors, in an interview with cnn.com.

September 13, 2023 | WUSA9

VERIFY: There is a Shortage of Endocrinologists, but Also of All Doctors

Researchers have been concerned about the number of practicing endocrinologists for at least two decades. AACE President Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, explains factors that may cause a shortage of endocrinologists and doctors overall, in an article featured on wusa9.com.

May 16, 2023 | Good Morning America

Exploring Side Effects of Popular Weight-loss Drugs

AACE President Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, appeared on Good Morning America about the side effects of the new class of weight-loss drugs that have seen a meteoric rise in popularity and use.

April 27, 2023 | CBS Evening News

Eli Lilly Seeks FDA Approval for Weight Loss Drug Tirzepatide

Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. AACE Treasurer Scott D. Isaacs, MD, FACP, FACE, spoke on CBS Evening News to provide expert health commentary as a leader in the endocrine field and steward of AACE.